Cooperation between a tumor protease (MT4-MMP) and a host-derived protease inhibitor (PAI-1) in tumor growth and metastatic dissemination

Chabottaux; Marc Thiry; Catherine Maillard; Peter Carmeliet; Jean-Michel Foidart; Agnès Noël

Related publications

Article2004

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Khalid Bajou, Catherine Maillard, Maud Jost, Roger Lijnen, Ann Gils, Paul Declerck, Peter Carmeliet, Jean-Michel Foidart, Agnès Noël

Article2000

Paradoxical increase of plaque growth and collagen deposition in atherosclerotic mice lacking plasminogen activator inhibitor-1 (PAI-1)

Aernout Luttun, J‐M. Herbert, Lieve Moons, Peter G. Tipping, D Collen, Florea Lupu, Peter Carmeliet

Article1999

Regular Exercise, Plasminogen Activator Inhibitor-1 (PAI-1) Activity and the 4G/5G Promoter Polymorphism in the PAI-1 Gene

Sari Väisänen, Steve E. Humphries, L A Luong, I Penttilä, Claude Bouchard, R. Rauramaa

Thrombosis and Haemostasis

Article2001

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

Khalid Bajou, Véronique Masson, Robert D. Gerard, Petra M. Schmitt, Valérie Albert, Michael Praus, Leif R. Lund, Thomas Leth Frandsen, Nils Brünner, Keld Danø, Norbert E. Fusenig, Ulrich H. Weidle, Geert Carmeliet, David J. Loskutoff, D Collen, Peter Carmeliet, Jean‐Michel Foidart, Agnès Noël

Article2003

Plasminogen activator inhibitor type-1 deficient (PAI-/-) mice show an improved early host defence in E. coli peritonitits by a neutrophil-dependent mechanism

Sebastiaan Weijer, Sandrine Florquin, de M.A. Waard, Roger Lijnen, Peter Carmeliet, Tom van der Poll